Meningococcal disease is rare enough that most people will never see a case, and fast enough that the difference between a same-day emergency room visit and a next-morning appointment can be the difference between recovery and death.
CDC's most recent surveillance update reports 463 confirmed and probable U.S. cases in 2025 based on preliminary data, the second-largest annual number since 2013. The agency notes that cases "have increased sharply since 2021 and now exceed pre-pandemic levels," with serogroup Y driving much of the rise.
That matters right now for a specific reason. Families are heading into school start dates and college move-in, the period when adolescents and young adults enter the shared living and close-contact settings where transmission happens, and when a missed vaccine dose becomes a practical question rather than a paperwork one.
The Symptoms That Should Send Someone to an Emergency Room
The infection spreads through saliva and respiratory secretions during close or prolonged contact, such as sharing drinks, kissing, or living in shared quarters. It is not spread by casual contact.
Classic meningitis symptoms include sudden fever, severe headache, a stiff neck, nausea and vomiting, sensitivity to light, and confusion or unusual sleepiness. A person can go from feeling generally unwell to critically ill in a matter of hours.
The bloodstream form, meningococcal septicemia, can look different. Warning signs include severe muscle or limb pain, cold hands and feet, rapid breathing, diarrhea, and a rash of dark spots or bruising that does not fade when pressed with the side of a clear glass. That rash is a late sign. Waiting for it before seeking care is the most common and most dangerous mistake.
In infants, look for poor feeding, unusual irritability, a high-pitched cry, floppiness, and a bulging soft spot on the head. Neck stiffness is often absent in babies.
Marielle Fricchione, a pediatric infectious disease physician at Rush and chair of the Illinois Immunization Advisory Committee, described the clinical reality to ABC7 Chicago during a local outbreak earlier this year, saying, "It's a very fast-moving infection."
If meningococcal disease is a possibility, go to an emergency department and say so explicitly. Antibiotics started early change outcomes, and clinicians will draw blood and, when indicated, cerebrospinal fluid.
Not Everyone Presents with Meningitis
One reason cases get missed is that the current increase does not always look like the textbook.
In a 2024 health advisory, CDC reported that most cases caused by the sequence type 1466 strain of serogroup Y presented with something other than meningitis. About 64 percent presented with bacteremia and at least 4 percent with septic arthritis. Among patients with known outcomes, 18 percent died, higher than the historical case fatality rate of 11 percent for serogroup Y.
That advisory also documented who this strain has been affecting: disproportionately people aged 30 to 60, Black or African American people, and people with HIV. CDC's current surveillance page repeats those groups.
So the disease has two distinct risk pictures at once. Infants and adolescents carry the highest overall incidence rates, with the highest adolescent rates among people 16 through 23. The recent serogroup Y increase has concentrated in middle-aged adults.
What Recent Local Outbreaks Showed
Chicago's health department detected a cluster in January that grew to 10 cases with two deaths across January and February. Investigators found no epidemiologic link between the cases. The department distributed 800 doses of meningococcal vaccine to shelter residents and providers and declared the outbreak over in early March after two incubation periods passed without new cases.
Virginia's statewide serogroup Y outbreak, which ran from 2022 until it was declared concluded in February 2025, produced 41 confirmed cases and eight deaths. A common risk factor was never identified.
As of its most recent update, CDC has said it is not aware of any meningococcal outbreaks currently affecting the United States. Individual cases occur year-round, with the national peak typically in January through March.
The Vaccine Question Parents Are Asking
MenACWY vaccine is routinely recommended at ages 11 to 12 with a booster at 16, and MenB is available for adolescents and young adults. Many colleges require documentation of meningococcal vaccination before move-in.
The federal recommendation status became contested this year. The January 2026 federal schedule downgraded several routine childhood vaccines, including meningococcal vaccines, but a federal court stayed that schedule in March, restoring the recommendations that applied before January 5. The appeal is pending. Most states, and the American Academy of Pediatrics, have continued to recommend meningococcal vaccination on the prior schedule.
For a family, the operational answer is simpler than the policy fight. Check the school or college requirement, check the child's immunization record through the state registry, and ask the pediatrician what is due. The booster at 16 is the dose most often missed, and it lands in the years of highest adolescent risk.
Vaccines do not cover every strain, so vaccination does not remove the need to recognize symptoms.
What Close Contacts Should Do
When a case is confirmed, health departments identify close contacts and provide preventive antibiotics. Close contact generally means household members, intimate partners, and people who shared saliva or lived in the same room.
Anyone told by a health department that they are a close contact should take the prescribed prophylaxis promptly, regardless of vaccination status. CDC has detected penicillin- and ciprofloxacin-resistant serogroup Y isolates since 2019, which is why prophylaxis choices are made with local health department input rather than by default.
Contacts should still watch for symptoms after taking antibiotics, and seek emergency care if fever or severe headache develops.
What Happens Next
CDC updates national case data through its notifiable disease system weekly and publishes enhanced surveillance reports annually, with the 2023 final report the most recent posted. Final 2025 figures will replace the preliminary 463 count.
The near-term watch items are local: school and college health offices reporting vaccination compliance in August and September, and any state or county advisory issued as students return. MedicalDaily will follow the appellate ruling on the federal schedule and any new local clusters.
Frequently Asked Questions
How common is meningococcal disease? It is rare. CDC reported 463 confirmed and probable U.S. cases in 2025, the second-largest number since 2013.
What symptoms mean I should go to the emergency room? Sudden fever with severe headache, stiff neck, confusion, vomiting, light sensitivity, severe limb pain, or a rash of dark spots that does not fade under pressure.
Does the rash always appear? No. The rash is often a late sign and may never appear. Do not wait for it before seeking care.
How does it spread? Through saliva and respiratory secretions during close or prolonged contact, such as sharing drinks or living in shared quarters. Not through casual contact.
Who is most at risk? Infants under one and adolescents have the highest incidence rates. The recent serogroup Y increase has affected adults 30 to 60, Black or African American people, and people with HIV.
Is the vaccine still recommended? Yes. MenACWY is recommended at 11 to 12 with a booster at 16 under the schedule currently in effect following a March court order, and most states follow it.
What if I was near someone who was diagnosed? Health departments contact close contacts and provide preventive antibiotics. Take them promptly and still watch for symptoms.
